ifosfamide has been researched along with Kidney Failure, Chronic in 11 studies
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sixteen pediatric osteosarcoma patients, previously treated with conventional chemotherapy (including ifosfamide (IFX), 9 g/m(2)) were retreated with high-dose ifosfamide (HD-IFX, 14 g/m(2) per course), following relapse or development of a new bone tumor." | 7.73 | High-dose ifosfamide in relapsed pediatric osteosarcoma: therapeutic effects and renal toxicity. ( Berberoğlu, S; Berrak, SG; Ilhan, IE; Jaffe, N; Pearson, M, 2005) |
| "A 67-year-old male patient developed progressive renal failure following successful treatment of a soft tissue sarcoma that comprised surgical resection after neoadjuvant radiochemotherapy with the application of doxorubicin (cumulative dose 180 mg/m²) and ifosfamide (cumulative dose 33 g/m²)." | 3.80 | [End-stage renal disease after sarcoma therapy - case 3/2014]. ( Amann, K; Artunc, F; Bakos, G; Baumann, D; Bunz, H; Ciarimboli, G; Kluba, T; Kopp, HG; Müller, M; Schlatter, E; Steinke, I; Weyrich, P, 2014) |
| "Sixteen pediatric osteosarcoma patients, previously treated with conventional chemotherapy (including ifosfamide (IFX), 9 g/m(2)) were retreated with high-dose ifosfamide (HD-IFX, 14 g/m(2) per course), following relapse or development of a new bone tumor." | 3.73 | High-dose ifosfamide in relapsed pediatric osteosarcoma: therapeutic effects and renal toxicity. ( Berberoğlu, S; Berrak, SG; Ilhan, IE; Jaffe, N; Pearson, M, 2005) |
| "Ifosfamide is a nitrogen mustard alkylating agent used as both a first-line and a salvage chemotherapeutic agent in the treatment of testicular germ cell tumors, various sarcomas, carcinomas, and some lymphomas." | 1.40 | Chronic Ifosfamide toxicity: kidney pathology and pathophysiology. ( Akilesh, S; Duffield, JS; Juaire, N; Smith, KD, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akilesh, S | 1 |
| Juaire, N | 1 |
| Duffield, JS | 1 |
| Smith, KD | 1 |
| Baumann, D | 1 |
| Amann, K | 1 |
| Schlatter, E | 1 |
| Ciarimboli, G | 1 |
| Kopp, HG | 1 |
| Müller, M | 1 |
| Kluba, T | 1 |
| Bakos, G | 1 |
| Steinke, I | 1 |
| Bunz, H | 1 |
| Weyrich, P | 1 |
| Artunc, F | 1 |
| Berrak, SG | 1 |
| Pearson, M | 1 |
| Berberoğlu, S | 1 |
| Ilhan, IE | 1 |
| Jaffe, N | 1 |
| Keaney, CM | 1 |
| Springate, JE | 1 |
| Krämer, A | 2 |
| Goldschmidt, H | 1 |
| Hahn, U | 1 |
| Andrassy, K | 2 |
| Berns, JS | 1 |
| Haghighat, A | 1 |
| Staddon, A | 1 |
| Cohen, RM | 1 |
| Schmidt, R | 1 |
| Fisher, S | 1 |
| Rudnick, MR | 1 |
| Tomaszewski, JE | 1 |
| Prasad, VK | 1 |
| Lewis, IJ | 1 |
| Aparicio, SR | 1 |
| Heney, D | 1 |
| Hale, JP | 1 |
| Bailey, CC | 1 |
| Kinsey, SE | 1 |
| Martinez, F | 1 |
| Deray, G | 1 |
| Cacoub, P | 1 |
| Beaufils, H | 1 |
| Jacobs, C | 1 |
| Friedlaender, MM | 1 |
| Haviv, YS | 1 |
| Rosenmann, E | 1 |
| Peylan-Ramu, N | 1 |
| Girón, FF | 1 |
| de la Vega, RL | 1 |
| Eguinoa, JE | 1 |
| Perez, MJ | 1 |
| Sanchez, MB | 1 |
| Rodriguez, CS | 1 |
| Rico, JM | 1 |
| Ho, AD | 1 |
1 review available for ifosfamide and Kidney Failure, Chronic
| Article | Year |
|---|---|
Cancer and the kidney.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carcinoma, Renal Cell; Comorbi | 2005 |
10 other studies available for ifosfamide and Kidney Failure, Chronic
| Article | Year |
|---|---|
Chronic Ifosfamide toxicity: kidney pathology and pathophysiology.
Topics: Antineoplastic Agents, Alkylating; Biopsy; Dose-Response Relationship, Drug; Drug Administration Sch | 2014 |
[End-stage renal disease after sarcoma therapy - case 3/2014].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Differential | 2014 |
High-dose ifosfamide in relapsed pediatric osteosarcoma: therapeutic effects and renal toxicity.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Female; Hu | 2005 |
Progressive renal failure in two breast cancer patients after high-dose ifosfamide.
Topics: Adult; Breast Neoplasms; Female; Humans; Ifosfamide; Kidney Failure, Chronic; Middle Aged | 1994 |
Severe, irreversible renal failure after ifosfamide treatment. A clinicopathologic report of two patients.
Topics: Antineoplastic Agents, Alkylating; Humans; Ifosfamide; Kidney; Kidney Failure, Chronic; Male; Middle | 1995 |
Progressive glomerular toxicity of ifosfamide in children.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Child; Child, Preschool; Creatinine; Female; Glomerul | 1996 |
Ifosfamide nephrotoxicity: deleterious effect of previous cisplatin administration.
Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Female; Humans; Ifosfamide; Kidney Failure, Chronic; | 1996 |
End-stage renal interstitial fibrosis in an adult ten years after ifosfamide therapy.
Topics: Adult; Antineoplastic Agents, Alkylating; Fibrosis; Humans; Ifosfamide; Kidney; Kidney Failure, Chro | 1998 |
End-stage chronic renal failure secondary to cisplatin and ifosfamide combination chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Humans; Ifosfamide; Kidney; Kidney | 1999 |
Renal failure after bone marrow transplantation.
Topics: Acute Kidney Injury; Bone Marrow Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Kidn | 2001 |